Edesa Biotech Inc (EDSA)
3.60
-0.03 -0.82%
NASDAQ
Feb 21, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 0.6364M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.437 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -4.999M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 96.50% |
| Profit Margin (Quarterly) | -1.02K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 31.89M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 28.65 |
| PE Ratio | -- |
| Price to Book Value | 7.533 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -0.7897M |
| Return on Equity | Upgrade |
View All EDSA News
News
-
WireHeadlineTime (ET)
-
SA Breaking News02/13 16:34
-
Accesswire02/13 16:10
-
MT Newswires01/06 16:49
-
MT Newswires01/06 13:28
-
SA Breaking News01/06 12:36
-
SA Breaking News01/06 11:05
-
SA Breaking News01/06 10:15
-
Accesswire01/06 09:21
-
SA Breaking News12/12 16:35
-
Accesswire12/12 16:30
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/05/2020 | Earnings | Edesa Biotech Inc First Quarter Earnings Results in 2020 |
| 12/12/2019 | Earnings | Edesa Biotech Inc Fourth Quarter Earnings Results for 2019 |
| 12/12/2019 | Misc | Edesa Biotech Inc Annual Report for 2019 |
| 08/14/2019 | Earnings | Edesa Biotech Inc Third Quarter Earnings Results in 2019 |
| 06/10/2019 | Splits | Ratio: 1666667:10000000 |
| 05/08/2019 | Earnings | Edesa Biotech Inc Second Quarter Earnings Results in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.edesabiotech.com
- Investor Relations URL: http://ir.stellarbiotechnologies.com/
- HQ State/Province: Ontario
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: N/A
- Last Earnings Release: Feb. 05, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Edesa Biotech Inc is a biopharmaceutical company focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.60 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EDSA Tweets Stocktwits
Advertisement
